Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT1 | P35610 | 1/20 | 0.73 |
| ▸ | ACAT1 | P24752 | 1/20 | 0.72 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6637903 | 0.98 | SOAT1 (0.76) | SOAT1ACAT1PDE4AKCNH2RXFP1 | |
| SCHEMBL6635350 | 0.95 | SOAT1 (0.68) | SOAT1ACAT1PDE4AKCNH2 | |
| SCHEMBL6635347 | 0.93 | SOAT1 (0.66) | SOAT1ACAT1PDE4AKCNH2RXFP1 | |
| SCHEMBL6641577 | 0.93 | SOAT1 (0.64) | SOAT1ACAT1 | |
| SCHEMBL6639853 | 0.92 | ACAT1 (0.85) | SOAT1ACAT1PDE4AKCNH2 | |
| SCHEMBL6635246 | 0.92 | SOAT1 (0.66) | SOAT1ACAT1PDE4AKCNH2 | |
| SCHEMBL6641829 | 0.90 | SOAT1 (0.63) | SOAT1ACAT1 | |
| SCHEMBL6637874 | 0.90 | SOAT1 (0.62) | SOAT1ACAT1PDE4AKCNH2RXFP1 | |
| SCHEMBL6635258 | 0.90 | ACAT1 (0.89) | SOAT1ACAT1PDE4AKCNH2 | |
| SCHEMBL6633500 | 0.89 | SOAT1 (0.59) | SOAT1ACAT1RXFP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0842933-B1 | NOVEL NAPHTHYRIDINE DERIVATIVES | SUMITOMO PHARMA (JP) | 2004-08-04 | — | — | EP | disclosed |
| EP-0842933-A1 | NOVEL NAPHTHYRIDINE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1998-05-20 | — | — | EP | disclosed |